Torsten Falk

This study shows that sub-anesthetic ketamine reduces dyskinesia caused by D2R-like receptor agonists but not D1R-like receptor agonists in L-DOPA-primed rats.

This study shows that sub-anesthetic ketamine reduces dyskinesia and improves motor function in female preclinical models of Parkinson's disease and L-DOPA-induced dyskinesia.

This study shows that L-DOPA improves certain motor features but not others in a bimanual string-pulling task in Parkinsonian rats.

This study shows that low-dose ketamine protects against Parkinson's-like motor deficits in rats without relying on BDNF-TrkB signaling.

This study shows that early administration of a PACAP agonist prevents mTBI-induced LHb hyperactivity and motivational deficits in mice, while late administration has limited efficacy and potential side effects.

This study examines how different statins affect the anti-dyskinetic effects of sub-anesthetic ketamine in a rat model of L-DOPA-induced dyskinesia.

This study shows that blocking kappa opioid receptors increases the rate of L-DOPA-induced dyskinesia development in a rat Parkinson's model but does not affect motor symptoms or tonic dopamine levels.

The paper investigates how heterogeneous neuronal activity in the ventral tegmental area coordinates dopamine release in the nucleus accumbens of anesthetized rats.